IOV-3001

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NameIOV-3001
Drug Alias NameNext generation IL-2 for TIL treatment regimenIOV-3001
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsUveal melanomaMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsUveal melanomaMelanoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A